title: Influence of the transjugular intrahepatic portosystemic stent on firstline treatment of hepatocellular carcinoma.
authors.affiliation: Department of Medicine II, University Hospital Freiburg, Freiburg, Germany.
authors.forename: Eva
authors.initials: E
authors.lastname: Knüppel
authors.forename: Dominik
authors.initials: D
authors.lastname: Bettinger
authors.forename: Wulf
authors.initials: W
authors.lastname: Euringer
authors.forename: Robert
authors.initials: R
authors.lastname: Thimme
authors.forename: Martin
authors.initials: M
authors.lastname: Roessle
authors.forename: Hans Christian
authors.initials: HC
authors.lastname: Spangenberg
authors.forename: Michael
authors.initials: M
authors.lastname: Schultheiβ
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery; D016461:Chemoembolization, Therapeutic; D006801:Humans; D006975:Hypertension, Portal / Q000601:surgery; D008113:Liver Neoplasms / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery; D019168:Portasystemic Shunt, Transjugular Intrahepatic / Q000401:mortality*; D015021:Yttrium Radioisotopes / Q000627:therapeutic use
chemical_list: D015021:Yttrium Radioisotopes